Clinical trial
Heart Failure and Peritoneal Ultrafiltration
NCT00368641 · Vantive Health LLC, Industry · Terminated
Key facts
| NCT number | NCT00368641 |
|---|---|
| Title | Heart Failure and Peritoneal Ultrafiltration |
| Official title | Treatment-Resistant Heart Failure (HF) and Peritoneal Ultrafiltration (PUF): A Randomized Prospective Trial of Standard Care Versus Standard Care With Peritoneal Ultrafiltration in Patients With Treatment-Resistant Severe Heart Failure |
| Lead sponsor | Vantive Health LLC, Industry |
| Collaborators | Baxter Healthcare Corporation (Former Sponsor) |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Congestive Heart Failure |
| Intervention type | Drug |
| Interventions | Extraneal |
| Enrollment | 12 |
| Start date | Aug 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Aug 25, 2006 |
| Last update posted | Jul 15, 2025 |
| Countries | Australia, Belgium, Canada, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: